ReviewDrugs2022
Ocrelizumab: A Review in Multiple Sclerosis.
Yvette N LambPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
67 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewDrugs2022
Yvette N LambPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.